Table 4.
Risk factors for mortality (n = 33) versus survival (n = 97) on day-28
| Characteristics | Univariate analysis | Multivariable analysis | ||
|---|---|---|---|---|
| Odds ratio | p value | Odds ratio | p value | |
| Growth failure | 1.19 (0.48–2.94) | 0.69 | ||
| ACLF | 5.68 (1.57–20.5) | 0.008 | 5.41 (0.75–38.6) | 0.092 |
| Sepsis | 3.17 (1.34–7.49) | 0.009 | 3.85 (0.82–18.12) | 0.087 |
| BA | 2.05 (0.87–4.82) | 0.098 | ||
| INR ≥ 2.5 | 4.62 (1.88–11.34) | 0.001 | ||
| Bilirubin ≥ 300 μmol/L | 7.34 (2.83–19.0) | 0.000 | ||
| pCLIF-SOFA | 1.52 (1.27–1.81) | 0.000 | 1.76 (1.40–2.20) | 0.000 |
| PELD | 1.08 (1.03–1.12) | 0.000 | ||
Odds ratio are expressed as 95% (confidence interval)
ACLF acute-on-chronic liver failure, BA biliary atresia, INR International Normalized Ratio, pCLIF-SOFA Paediatric Chronic Liver Failure-Sequential Organ Failure Assessment score, PELD paediatric end-stage liver disease